Intas B2B Dossier e-portfolio
Access to Intas Intas Pharmaceutical portfolio.
App info
Advertisement
App description
Android App Analysis and Review: Intas B2B Dossier e-portfolio, Developed by Intas. Listed in Medical Category. Current Version Is 5.0.3, Updated On 16/04/2024 . According to users reviews on Google Play: Intas B2B Dossier e-portfolio. Achieved Over 6 thousand Installs. Intas B2B Dossier e-portfolio Currently Has 20 Reviews, Average Rating 4.1 Stars
Access to Intas B2B portfolio Global-Dossiers: Biosimilars, Added Value Medicines and Generics.Access to visual overviews on regulatory information and launch landscape.
Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.
Always updated with our last developments, filing plan and available MAs.
All the information also available off-line.
We are currently offering version 5.0.3. This is our latest, most optimized version. It is suitable for many different devices. Free download directly apk from the Google Play Store or other versions we're hosting. Moreover, you can download without registration and no login required.
We have more than 2000+ available devices for Samsung, Xiaomi, Huawei, Oppo, Vivo, Motorola, LG, Google, OnePlus, Sony, Tablet ... with so many options, it’s easy for you to choose games or software that fit your device.
It can come in handy if there are any country restrictions or any restrictions from the side of your device on the Google App Store.
